Cargando…

Pre-existing humoral immunity in military smallpox vaccinees temporally effects MVA-vectored transgene expression in dendritic cells

Detalles Bibliográficos
Autores principales:	Ngauy, V, Slike, B, Marovich, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442039/ http://dx.doi.org/10.1186/1742-4690-9-S2-P97

Ejemplares similares

Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations
por: Slike, Bonnie M., et al.
Publicado: (2017)

The Future of Smallpox Vaccination: is MVA the key?
por: Slifka, Mark K
Publicado: (2005)

OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees
por: Nilsson, C, et al.
Publicado: (2009)

Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate
por: Currier, Jeffrey R., et al.
Publicado: (2010)

Side-by-Side Comparison of Gene-Based Smallpox Vaccine with MVA in Nonhuman Primates
por: Golden, Joseph W., et al.
Publicado: (2012)

Secondary and Tertiary Transmission of Vaccinia Virus After Sexual Contact with a Smallpox Vaccinee — San Diego, California, 2012
por: Shao, Hai, et al.
Publicado: (2013)

Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines
por: Meseda, Clement A., et al.
Publicado: (2016)

Pre-existing immunity against Ad vectors: Humoral, cellular, and innate response, what's important?
por: Fausther-Bovendo, Hugues, et al.
Publicado: (2014)

Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood
por: Smith, Corinne J., et al.
Publicado: (2022)

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial
por: Nilsson, Charlotta, et al.
Publicado: (2015)

Adventitious viral genomes in vaccines but not in vaccinees.
por: Weiss, R A
Publicado: (2001)

On the Existing State of Our Knowledge of Vaccination and Re-Vaccination, as Preventive of Smallpox
Publicado: (1852)

Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus
por: Li, Entao, et al.
Publicado: (2023)

Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations
por: Palgen, Jean-Louis, et al.
Publicado: (2020)

Comparable antigen-specific T cell responses in vaccinees with diverse humoral immune responses after the primary and booster BBIBP-CorV vaccination
por: Wei, Dong, et al.
Publicado: (2022)

Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults
por: Green, Christopher A., et al.
Publicado: (2019)

Smallpox
por: Breman, Joel G
Publicado: (2021)

Smallpox
Publicado: (1899)

Smallpox
Publicado: (1871)

Neurologic adverse events associated with smallpox vaccination in the United States – response and comment on reporting of headaches as adverse events after smallpox vaccination among military and civilian personnel
por: Schumm, Walter R
Publicado: (2006)

Smallpox Illustrated: A Practical Treatise on Smallpox
por: Ker, Claude B.
Publicado: (1902)

Smallpox and New York City’s Smallpox Hospital
por: Spiegel, Allen D., et al.
Publicado: (2005)

Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals
por: Otter, Ashley D., et al.
Publicado: (2023)

Humoral immunogenicity of ChAd63_MVA ME-TRAP vaccination in African infants and children
por: Bowyer, Georgina, et al.
Publicado: (2014)

MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease
por: Liu, Ruikang, et al.
Publicado: (2021)

Smallpox Zero: An Illustrated History of Smallpox and Its Eradication
por: Stockton, P. Lynne
Publicado: (2010)

Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice
por: Kalodimou, Georgia, et al.
Publicado: (2023)

Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial
por: Overton, Edgar Turner, et al.
Publicado: (2018)

Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
por: Zolla-Pazner, Susan, et al.
Publicado: (2013)

Pre-existing immunity against vaccine vectors – friend or foe?
por: Saxena, Manvendra, et al.
Publicado: (2013)

Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose?
por: Achiron, Anat, et al.
Publicado: (2021)

Vaccinia and Smallpox
Publicado: (1901)

Smallpox and Sulphonamide
por: Patel, T. B., et al.
Publicado: (1940)

Observations on Smallpox
por: Ogston, Alex.
Publicado: (1873)

Vaccination for Smallpox
por: Prakash, Om
Publicado: (1946)

Vaccination for Smallpox
Publicado: (1946)

The Diagnosis of Smallpox
Publicado: (1912)

Smallpox in Calcutta
Publicado: (1951)

The Smallpox Outbreak
por: Loat, L.
Publicado: (1911)

The Progress of Smallpox
Publicado: (1871)

Cannot write session to /tmp/vufind_sessions/sess_27qu0mug07fi7h55mpbgfgvmjs